MedAdvisor Ltd
MDR
Company Profile
Business description
MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has three reporting segments: ANZ Operations, U.S. Operations and UK Operations. The company derives majority of its revenues from U.S. Operations.
Contact
971 Burke Road
Level 2
CamberwellVIC3124
AUST: +61 390953036
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
CBA earnings: The only thing that puzzles us is the share price
No surprises in fiscal 2025 earnings.
stocks
The best way to get rich and retire early
This goes through the different options including shares, property and business ownership and declares a winner, as well as outlining the mindset needed to earn enough to never have to work again.
stocks
Investors too optimistic about ASX growth story
Investors have gotten ahead of themselves with shares trading at a 94% premium to fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,103.10 | 47.20 | -0.52% |
| CAC 40 | 7,804.97 | 51.55 | 0.66% |
| DAX 40 | 24,185.59 | 160.81 | 0.67% |
| Dow JONES (US) | 44,767.28 | 308.67 | 0.69% |
| FTSE 100 | 9,165.23 | 17.42 | 0.19% |
| HKSE | 25,613.67 | 643.99 | 2.58% |
| NASDAQ | 21,701.54 | 19.64 | 0.09% |
| Nikkei 225 | 43,274.67 | 556.50 | 1.30% |
| NZX 50 Index | 12,766.54 | 6.86 | 0.05% |
| S&P 500 | 6,453.32 | 7.56 | 0.12% |
| S&P/ASX 200 | 8,827.10 | 53.70 | -0.60% |
| SSE Composite Index | 3,683.46 | 17.55 | 0.48% |